메뉴 건너뛰기




Volumn 16, Issue 1, 2010, Pages 42-51

Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany

Author keywords

EQ 5D; Health related quality of life; Inflammatory bowel disease

Indexed keywords

ADULT; ARTICLE; CONSTRUCT VALIDITY; CONTROLLED STUDY; CROHN DISEASE; DETERIORATION; DISEASE ACTIVITY; EUROQOL 5D; FEMALE; GERMANY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; REMISSION; SCORING SYSTEM; TEST RETEST RELIABILITY; ULCERATIVE COLITIS; UNITED KINGDOM; VISUAL ANALOG SCALE;

EID: 74049094313     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20989     Document Type: Article
Times cited : (80)

References (37)
  • 1
    • 0025688231 scopus 로고
    • a new facility for the measurement of health-related quality of life. The EuroQol Group
    • EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199-208.
    • (1990) Health Policy , vol.16 , pp. 199-208
    • EuroQol1
  • 2
    • 0029952658 scopus 로고    scopus 로고
    • EuroQol: The current state of play
    • Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53-72.
    • (1996) Health Policy , vol.37 , pp. 53-72
    • Brooks, R.1
  • 3
    • 0030102792 scopus 로고    scopus 로고
    • The time trade-off method: Results from a general population study
    • Dolan P, Gudex C, Kind P, et al. The time trade-off method: results from a general population study. Health Econ. 1996;5:141-154.
    • (1996) Health Econ , vol.5 , pp. 141-154
    • Dolan, P.1    Gudex, C.2    Kind, P.3
  • 4
    • 0036583365 scopus 로고    scopus 로고
    • Modelling valuations for Eq-5d health states: An alternative model using differences in valuations
    • Dolan P, Roberts J. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations. Med Care. 2002;40:442-446.
    • (2002) Med Care , vol.40 , pp. 442-446
    • Dolan, P.1    Roberts, J.2
  • 5
    • 14844319324 scopus 로고    scopus 로고
    • US valuation of the EQ-5D health states: Development and testing of the D1 valuation model
    • Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203-220.
    • (2005) Med Care , vol.43 , pp. 203-220
    • Shaw, J.W.1    Johnson, J.A.2    Coons, S.J.3
  • 6
    • 14944339043 scopus 로고    scopus 로고
    • Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data
    • Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ. 2005;14:217-230.
    • (2005) Health Econ , vol.14 , pp. 217-230
    • Bagust, A.1    Beale, S.2
  • 7
    • 34249026625 scopus 로고    scopus 로고
    • Mapping from disease-specific measures to utility: An analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility
    • Buxton MJ, Lacey LA, Feagan BG, et al. Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility. Value Health. 2007;10:214-220.
    • (2007) Value Health , vol.10 , pp. 214-220
    • Buxton, M.J.1    Lacey, L.A.2    Feagan, B.G.3
  • 8
    • 36849085854 scopus 로고    scopus 로고
    • The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning
    • Gunther OH, Roick C, Angermeyer MC, et al. The responsiveness of EQ-5D utility scores in patients with depression: a comparison with instruments measuring quality of life, psychopathology and social functioning. J Affect Disord. 2008;105:81-91.
    • (2008) J Affect Disord , vol.105 , pp. 81-91
    • Gunther, O.H.1    Roick, C.2    Angermeyer, M.C.3
  • 9
    • 41149145533 scopus 로고    scopus 로고
    • Comparing preference-based quality-of-life measures: Results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders
    • Moock J, Kohlmann T. Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual Life Res. 2008;17:485-495.
    • (2008) Qual Life Res , vol.17 , pp. 485-495
    • Moock, J.1    Kohlmann, T.2
  • 10
    • 22144486878 scopus 로고    scopus 로고
    • Measuring the quality of life in cost-utility analyses: The Dutch EQ-5D tariff
    • Lamers LM, Stalmeier PF, McDonnell J, et al. [Measuring the quality of life in cost-utility analyses: the Dutch EQ-5D tariff.]Ned Tijdschr Geneeskd. 2005;149:1574-1578.
    • (2005) Ned Tijdschr Geneeskd , vol.149 , pp. 1574-1578
    • Lamers, L.M.1    Stalmeier, P.F.2    McDonnell, J.3
  • 11
    • 21344450788 scopus 로고    scopus 로고
    • Validating the EQ-5D with Time Trade Off for the German Population
    • Greiner W, Claes C, Busschbach JJV, et al. Validating the EQ-5D with Time Trade Off for the German Population. Eur J Health Econ. 2005;62:124-130.
    • (2005) Eur J Health Econ , vol.62 , pp. 124-130
    • Greiner, W.1    Claes, C.2    Busschbach, J.J.V.3
  • 12
    • 0031134856 scopus 로고    scopus 로고
    • Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D)
    • Hurst NP, Kind P, Ruta D, et al. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol. 1997;36:551-559.
    • (1997) Br J Rheumatol , vol.36 , pp. 551-559
    • Hurst, N.P.1    Kind, P.2    Ruta, D.3
  • 13
    • 29644438442 scopus 로고    scopus 로고
    • Validation of the EuroQol questionnaire in cardiac rehabilitation
    • Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart. 2006;92:62-67.
    • (2006) Heart , vol.92 , pp. 62-67
    • Schweikert, B.1    Hahmann, H.2    Leidl, R.3
  • 14
    • 4344629965 scopus 로고    scopus 로고
    • Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30
    • Krabbe PF, Peerenboom L, Langenhoff BS, Ruers TJ. Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30. Qual Life Res. 2004;13:1247-1253.
    • (2004) Qual Life Res , vol.13 , pp. 1247-1253
    • Krabbe, P.F.1    Peerenboom, L.2    Langenhoff, B.S.3    Ruers, T.J.4
  • 15
    • 0033850179 scopus 로고    scopus 로고
    • Quality of life measurement in gastrointestinal and liver disorders
    • Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut. 2000;47:444-454.
    • (2000) Gut , vol.47 , pp. 444-454
    • Borgaonkar, M.R.1    Irvine, E.J.2
  • 16
    • 0002027876 scopus 로고    scopus 로고
    • Inflammatory bowel disease
    • Spilker B, ed, 2nd edition. Philadelphia: Lippincott-Raven;
    • Drossman DA. Inflammatory bowel disease. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edition. Philadelphia: Lippincott-Raven;1996:925-935.
    • (1996) Quality of Life and Pharmacoeconomics in Clinical Trials , pp. 925-935
    • Drossman, D.A.1
  • 18
    • 2442563304 scopus 로고    scopus 로고
    • Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
    • Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
    • (2004) Gastroenterology , vol.126 , pp. 1504-1517
    • Loftus Jr., E.V.1
  • 19
    • 0032878965 scopus 로고    scopus 로고
    • Economic issues in Crohn's disease - assessing the effects of new treatments on health-related quality of life
    • Feagan BG. Economic issues in Crohn's disease - assessing the effects of new treatments on health-related quality of life. Aliment Pharmacol Ther. 1999;13:29-37.
    • (1999) Aliment Pharmacol Ther , vol.13 , pp. 29-37
    • Feagan, B.G.1
  • 21
    • 33845284915 scopus 로고    scopus 로고
    • The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life
    • Graff LA, Walker JR, Lix L, et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006;4:1491-1501.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 1491-1501
    • Graff, L.A.1    Walker, J.R.2    Lix, L.3
  • 22
    • 25444470762 scopus 로고    scopus 로고
    • Psychological stress in IBD: New insights into pathogenic and therapeutic implications
    • Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54:1481-1491.
    • (2005) Gut , vol.54 , pp. 1481-1491
    • Mawdsley, J.E.1    Rampton, D.S.2
  • 23
    • 42449123196 scopus 로고    scopus 로고
    • Population-based controlled study of social support, self-perceived stress, activity and work issues, and access to health care in inflammatory bowel disease
    • Rogala L, Miller N, Graff LA, et al. Population-based controlled study of social support, self-perceived stress, activity and work issues, and access to health care in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:526-535.
    • (2008) Inflamm Bowel Dis , vol.14 , pp. 526-535
    • Rogala, L.1    Miller, N.2    Graff, L.A.3
  • 24
    • 59249094987 scopus 로고    scopus 로고
    • Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease
    • Lix LM, Graff LA, Walker JR, et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1575-1584.
    • (2008) Inflamm Bowel Dis , vol.14 , pp. 1575-1584
    • Lix, L.M.1    Graff, L.A.2    Walker, J.R.3
  • 25
    • 33750460595 scopus 로고    scopus 로고
    • Responsiveness and minimal important differences for patient reported outcomes
    • Revicki DA, Cella D, Hays RD, et al. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes. 2006;4:70.
    • (2006) Health Qual Life Outcomes , vol.4 , pp. 70
    • Revicki, D.A.1    Cella, D.2    Hays, R.D.3
  • 26
    • 0036195669 scopus 로고    scopus 로고
    • Methods to explain the clinical significance of health status measures
    • Guyatt GH, Osoba D, Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77:371-383.
    • (2002) Mayo Clin Proc , vol.77 , pp. 371-383
    • Guyatt, G.H.1    Osoba, D.2    Wu, A.W.3
  • 27
    • 0036863322 scopus 로고    scopus 로고
    • Validation of the EuroQol questionnaire in patients with inflammatory bowel disease
    • Konig HH, Ulshofer A, Gregor M, et al. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14:1205-1215.
    • (2002) Eur J Gastroenterol Hepatol , vol.14 , pp. 1205-1215
    • Konig, H.H.1    Ulshofer, A.2    Gregor, M.3
  • 28
    • 0035085427 scopus 로고    scopus 로고
    • Impaired health-related quality of life in inflammatory bowel diseases: Psychosocial impact and coping styles in a national German sample
    • Petrak F, Hardt J, Clement T, et al. Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol. 2001;36:375-382.
    • (2001) Scand J Gastroenterol , vol.36 , pp. 375-382
    • Petrak, F.1    Hardt, J.2    Clement, T.3
  • 29
    • 0017227303 scopus 로고
    • Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
    • Best WR BJ, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
    • (1976) Gastroenterology , vol.70 , pp. 439-444
    • Best, W.B.1    Singleton, J.W.2    Kern Jr, F.3
  • 30
    • 0024587677 scopus 로고
    • Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
    • Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298:82-86.
    • (1989) BMJ , vol.298 , pp. 82-86
    • Rachmilewitz, D.1
  • 31
    • 3042847146 scopus 로고    scopus 로고
    • Questions on life satisfaction (FLZM) in inflammatory bowel disease
    • Janke KH, Raible A, Bauer M, et al. Questions on life satisfaction (FLZM) in inflammatory bowel disease. Int J Colorectal Dis. 2004;19:343-353.
    • (2004) Int J Colorectal Dis , vol.19 , pp. 343-353
    • Janke, K.H.1    Raible, A.2    Bauer, M.3
  • 32
    • 48249153186 scopus 로고
    • Intraclass correlations: Uses in assessing rater reliability
    • Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420-428.
    • (1979) Psychol Bull , vol.86 , pp. 420-428
    • Shrout, P.E.1    Fleiss, J.L.2
  • 33
    • 0025851102 scopus 로고
    • Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation
    • Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials. 1991;12:142S-158S.
    • (1991) Control Clin Trials , vol.12
    • Deyo, R.A.1    Diehr, P.2    Patrick, D.L.3
  • 34
    • 18544372466 scopus 로고    scopus 로고
    • Understanding interobserver agreement: The kappa statistic
    • Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360-363.
    • (2005) Fam Med , vol.37 , pp. 360-363
    • Viera, A.J.1    Garrett, J.M.2
  • 35
    • 33747198336 scopus 로고    scopus 로고
    • Costs of inflammatory bowel disease in Germany
    • Stark R, Konig HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics. 2006;24:797-814.
    • (2006) Pharmacoeconomics , vol.24 , pp. 797-814
    • Stark, R.1    Konig, H.H.2    Leidl, R.3
  • 36
    • 34547916569 scopus 로고    scopus 로고
    • Statistical significant change versus relevant or important change in (quasi) experimental design: Some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research
    • Middel B, van Sonderen E. Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research. Int J Integr Care. 2002;2:e15.
    • (2002) Int J Integr Care , vol.2
    • Middel, B.1    van Sonderen, E.2
  • 37
    • 39749097822 scopus 로고    scopus 로고
    • Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
    • Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5:70.
    • (2007) Health Qual Life Outcomes , vol.5 , pp. 70
    • Pickard, A.S.1    Neary, M.P.2    Cella, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.